|
|
 | | | |
- close
- close
- close
- close
QUOTE AND NEWS
PR Newswire
5 hrs ago
Comment
MENLO PARK, Calif., May 25, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Jefferies Global Health Care Conference in New York City. The presentation at the Jefferies conference is scheduled for
Benzinga
May 11
Comment
Depomed, Inc. (NASDAQ: DEPO) today announced that it has received a $1 million milestone payment from Ironwood Pharmaceuticals, Inc. following the development and delivery of a prototype formulation of an Ironwood development candidate meeting...
PR Newswire
May 10
Comment
MENLO PARK, Calif., May 10, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada. The presentation at the B of A conference is
StreetInsider.com
May 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/DepoMed%2C+Inc.+%28DEPO%29+Tops+Q1+EPS+by+8c/7416577.html for the full story.
PR Newswire
May 8
Comment
MENLO PARK, Calif., May 8, 2012 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today reported financial results for the quarter ended March 31, 2012. 2012 First Quarter Business Highlights -- Financial Highlights: -- Revenue of $16.8 million -- Net
Globe Newswire
May 1
Comment
MENLO PARK, Calif., May 1, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it will release its first quarter financials after the market close on May 8, 2012 and that it will be presenting at the 11th Annual JMP Research
Apr 25
Comment
On April 17, 2012, Depomed (DEPO) announced it had completed a Type B “pre-NDA” meeting with the U.S. FDA regarding the results of the three phase 3 clinical trials for Serada (extended-release gabapentin tablets). Following the meeting,...
StreetInsider.com
Apr 19
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Watson+%28API%29+Affirms+Submission+of+NDA+to+FDA+for+Generic+Glumetza+%28DEPO%29/7356989.html for the full story.
StreetInsider.com
Apr 18
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Valeant+%28VRX%29%2C+DepoMed+%28DEPO%29+Sue+Watson+%28WPI%29+Over+Generic+Glumetza/7354545.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
